Dr. Calvin W. Roberts, also known as Cal, M.D., has been the Chief Medical Officer of Ophthalmology & Eye Health at Valeant Pharmaceuticals International, Inc. since August 2013. Dr. Roberts has been Chief Medical Officer and Executive Vice President at Bausch & Lomb Holdings Incorporated since March 2011. He serves as the Chief Medical Officer and Executive Vice President at Bausch & Lomb Holdings Incorporated. Dr. Roberts has been the Chief Medical Officer of Bausch & Lomb Incorporated since March 2011 and also serves as its Executive Vice President. He serves as a Member of the Executive Leadership Team at Bausch & Lomb and coordinate its global D&R efforts across the Vision Care, Pharmaceuticals and Surgical business units for greater leverage and outcomes. He has been a Clinical Professor of ophthalmology at Weill Medical College of Cornell University since 1982. He has been a Consultant to ophthalmic pharmaceutical companies, including Allergan Pharmaceuticals, Johnson & Johnson and Novartis since 1989. He served as Corporate Vice President at Bausch & Lomb Incorporated since March 2011. He has been an Independent Director at Alimera Sciences, Inc. since 2003. He has been a Director at Alimera Sciences Limited since 2003. He has been a Director of Auris Medical Holding AG since April 2015. He served as Founding Director of Alimera Sciences, Inc. He holds patents on the wide-field specular microscope, used for corneal endothelial studies and is the developer of instruments for cataract surgery. He

Opthalmology